Prostate Cancer as a Model System for Genetic Diversity in Tumors-Reference-Cited by-同舟云学术

Prostate Cancer as a Model System for Genetic Diversity in Tumors

Published:2011 Issue: Volume: Page:183-216
ISSN:0065-230X
Container-title:Advances in Cancer Research
language:
Short-container-title:

Author:

Squire Jeremy A.,Park Paul C.,Yoshimoto Maisa,Alami Jennifer,Williams Julia L.,Evans Andrew,Joshua Anthony M.

Publisher

Elsevier

Reference208 articles.

1. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia;Afar;Cancer Res.,2001

2. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer;Ai;Mol. Endocrinolo,2009

3. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Nat. Acad. Sci. USA,2003

4. TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma;Albadine;Mod. Pathol.,2009

5. Subtle variations in Pten dose determine cancer susceptibility;Alimonti;Nat. Genet.,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer;Biomedical Aspects of Solid Cancers;2024

2. The Relationship between Telomere Length and Nucleoplasmic Bridges and Severity of Disease in Prostate Cancer Patients;Cancers;2023-06-26

3. In-Silico Molecular Docking, Validation, Drug- Likeness, and ADMET Studies of Antiandrogens to Use in the Fight against SARS-CoV-2;PHYS CHEM RES;2023

4. HDAC inhibition in cancer;Epigenetics in Organ Specific Disorders;2023

5. Enzymes in the time of COVID‐19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs;Medicinal Research Reviews;2022-06-28